| Nanoparticle biointerfacing by platelet membrane cloaking CMJ Hu, RH Fang, KC Wang, BT Luk, S Thamphiwatana, D Dehaini, ... Nature 526 (7571), 118-121, 2015 | 1428 | 2015 |
| Cell membrane coating nanotechnology RH Fang, AV Kroll, W Gao, L Zhang Advanced materials 30 (23), 1706759, 2018 | 1231 | 2018 |
| Erythrocyte–platelet hybrid membrane coating for enhanced nanoparticle functionalization D Dehaini, X Wei, RH Fang, S Masson, P Angsantikul, BT Luk, Y Zhang, ... Advanced Materials 29 (16), 1606209, 2017 | 603 | 2017 |
| Reversible centriole depletion with an inhibitor of Polo-like kinase 4 YL Wong, JV Anzola, RL Davis, M Yoon, A Motamedi, A Kroll, CP Seo, ... Science 348 (6239), 1155-1160, 2015 | 425 | 2015 |
| Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity AV Kroll, RH Fang, Y Jiang, J Zhou, X Wei, CL Yu, J Gao, BT Luk, ... Advanced materials 29 (47), 1703969, 2017 | 421 | 2017 |
| Biointerfacing and applications of cell membrane-coated nanoparticles AV Kroll, RH Fang, L Zhang Bioconjugate chemistry 28 (1), 23-32, 2017 | 297 | 2017 |
| Biomimetic nanotechnology toward personalized vaccines J Zhou, AV Kroll, M Holay, RH Fang, L Zhang Advanced materials 32 (13), 1901255, 2020 | 256 | 2020 |
| Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis X Wei, M Ying, D Dehaini, Y Su, AV Kroll, J Zhou, W Gao, RH Fang, ... ACS nano 12 (1), 109-116, 2018 | 241 | 2018 |
| Engineered cell‐membrane‐coated nanoparticles directly present tumor antigens to promote anticancer immunity Y Jiang, N Krishnan, J Zhou, S Chekuri, X Wei, AV Kroll, CL Yu, Y Duan, ... Advanced Materials 32 (30), 2001808, 2020 | 226 | 2020 |
| Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia X Wei, J Gao, RH Fang, BT Luk, AV Kroll, D Dehaini, J Zhou, HW Kim, ... Biomaterials 111, 116-123, 2016 | 167 | 2016 |
| Nanoparticle‐based manipulation of antigen‐presenting cells for cancer immunotherapy RH Fang, AV Kroll, L Zhang Small 11 (41), 5483-5496, 2015 | 117 | 2015 |
| Nanoparticle‐Based Antivirulence Vaccine for the Management of Methicillin‐Resistant Staphylococcus aureus Skin Infection F Wang, RH Fang, BT Luk, CMJ Hu, S Thamphiwatana, D Dehaini, ... Advanced functional materials 26 (10), 1628-1635, 2016 | 112 | 2016 |
| Ultra-small lipid–polymer hybrid nanoparticles for tumor-penetrating drug delivery D Dehaini, RH Fang, BT Luk, Z Pang, CMJ Hu, AV Kroll, CL Yu, W Gao, ... Nanoscale 8 (30), 14411-14419, 2016 | 107 | 2016 |
| In situ capture of bacterial toxins for antivirulence vaccination X Wei, J Gao, F Wang, M Ying, P Angsantikul, AV Kroll, J Zhou, W Gao, ... Advanced Materials 29 (33), 1701644, 2017 | 106 | 2017 |
| Biomimetic nanoparticle vaccines for cancer therapy AV Kroll, Y Jiang, J Zhou, M Holay, RH Fang, L Zhang Advanced biosystems 3 (1), 1800219, 2019 | 85 | 2019 |
| Multiantigenic nanotoxoids for antivirulence vaccination against antibiotic-resistant gram-negative bacteria X Wei, D Ran, A Campeau, C Xiao, J Zhou, D Dehaini, Y Jiang, AV Kroll, ... Nano Letters 19 (7), 4760-4769, 2019 | 71 | 2019 |
| Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy DT Johnson, J Zhou, AV Kroll, RH Fang, M Yan, C Xiao, X Chen, J Kline, ... Leukemia 36 (4), 994-1005, 2022 | 39 | 2022 |
| Codelivery of antigens and adjuvant in polymeric nanoparticles coated with native parasite membranes induces protective mucosal immunity against Giardia lamblia J Zhou, Y Miyamoto, S Ihara, AV Kroll, N Nieskens, VN Tran, EM Hanson, ... The Journal of Infectious Diseases 226 (2), 319-323, 2022 | 9 | 2022 |
| Nano‐immunoengineering: Nanoparticle‐Based Manipulation of Antigen‐Presenting Cells for Cancer Immunotherapy (Small 41/2015) RH Fang, AV Kroll, L Zhang Small 11 (41), 5466-5466, 2015 | 2 | 2015 |
| Cell Membrane-Coated Nanoparticles for Immune Modulation A Kroll University of California, San Diego, 2019 | | 2019 |
